Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?

Vaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market trade this morning. NVAX stock is up over 300% year-to-date. NVAX stock is due to open today at $24.10 per share, a market capitalization of about $3.6 billion on 2023 revenue of $656 million. But Novavax lost the race to deliver its vaccines to Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA). Shares fell to below $10 in 2023. Talk show host Peter Sagal recently missed a show because of Covid. Singer Linda Ronsta ...